Jackson Hole Seminars







Educational Advisory Board

Jack W. McAninch,M.D.
   San Francisco, CA
Gerald H. Jordan, M.D.
   Norfolk, VA
Culley C. Carson, M.D.
   Chapel Hill, NC
Carl G. Klutke, M.D.
   St. Louis, MO
Fernando J. Kim, M.D. FACS
   Denver, CO

Saturday, February 6, 2010

4:00 – 6:00

Registration

Sunday, February 7, 2010

7:00 - 7:20

Managing the Urethra at the Time of Pelvic Organ Prolapse Repair: A Selective Approach to Simultaneous Anti-incontinence Surgery- Victor Nitti, MD

7:20 - 7:40

Extraperitoneal Access to Robotic Radical Prostatectomy – Ingolf Tuerk, MD

7:40 - 8:00

Anti-Fibrotic Therapies for Penile Deformities – Arthur Burnett, MD

8:00 - 8:20

Prostate Cancer Screening Using PSA – Judd Moul, MD

8:20 - 8:40

Break

8:40 - 9:00

Evaluation and Treatment of Ureteropelvic Junction Obstruction in 2010 – Michael Fabrizio, MD

9:00 - 9:20

Intravesical and Chemo and Immunotherapy for Non-muscle Invasive Bladder Cancer - Yves Fradet, MD

9:20 - 4:00

Break 

4:00 - 4:20

Robot-unassisted Treatment of Prostate Cancer: Active Surveillance Update – John Davis, MD

4:20 - 4:30

Break

4:30 -7:20

Critique Panel

Monday, February 8, 2010

7:00 - 7:20

Urological Complications of Type 1 Diabetes: The UroEDICStudy - Hunter Wessells, MD

7:20 - 7:40

Can We Define Quality Bladder Cancer Care?- James Montie, MD

7:40 - 8:00

Treatment of Urge Incontinence When Drugs Aren't Working. – Ann Gormley, MD

8:00 - 8:20

Radical Prostatectomy: Where Are We Going? - Joel Nelson, MD

8:20 - 8:40

Break

8:40 - 9:00

PDE5 inhibitors for LUTS/BPH – Kevin McVary, MD

9:00 - 9:20

Rationale for Kidney-Sparing Surgery for Stage T1, Renal Cell Carcinoma- Michael Blute, MD

9:20 - 4:00

Break

4:00 - 4:20

The Association Between Cardiovascular Disease and Kidney Stones – Marshall Stoller, MD

4:20 - 4:30

Break

4:30 -7:20

Critique Panel

Tuesday, February 9, 2010

7:00 - 7:20

Managing Complications of Mid-urethral Synthetic Slings: Obstruction, Erosion and Extrusion - Victor Nitti, MD 

7:20 - 7:40

Preservation of Continence and Potency During RALP – Ingolf Tuerk, MD

7:40 - 8:00

Endoscopic Treatment of Upper Tract Urothelial Malignancy in 2010 - Michael Fabrizio,MD

8:00 - 8:20

Renal Ischemia-Reperfusion Injury and Renal Cell Culture: What Are the Clinical Implications? – Fernando Kim, MD

8:20 - 8:40

Break

8:40 - 9:00

New Molecular Markers for Prostate Cancer beyond PSA: A New Era - Yves Fradet, MD

9:00 - 9:20

 Penile Implants in the Era of Medical ED Treatment – Culley Carson, MD  

9:20 - 4:00

Break

4:00 - 4:20

Robot-assisted Radical Prostatectomy Outcomes: Making ME Better and Making YOU Better. – John Davis, MD

4:20- 4:30

Break

4:30 - 7:20

Critique Panel

Wednesday, February 10, 2010

7:00 - 7:20

PSA Following Surgery for BPH/LUTS Biomarker for Surgical Completeness? – Kevin McVary, MD

7:20 - 7:40

Emerging Therapies for Advanced Prostate Cancer - Joel Nelson, MD

7:40 - 8:00

GU Injuries: Treatment and Prevention Strategies - Hunter Wessells, MD

8:00 - 8:20

Female Prolapse Surgery: Uterine Preservation Techniques - Carl Klutke, MD

8:20 - 8:40

Break 

8:40 - 9:00

Value of Lymph Node Dissection In High-Risk Renal Cell Cancer – Michael Blute, MD

9:00 - 9:20

Management of the Bulbous Urethral Stricture - Jack McAninch, MD

9:20 - 4:00

Break 

4:00 - 4:20

Percutaneous Nephrolithotomy: Which Lower Pole Calyx to Access - Marshall Stoller, MD

4:20 - 4:30

Break

4:30 - 7:20

Critique Panel

Thursday, February 11, 2010

7:00 - 7:20

New Therapeutic Directions for Erection Preservation after Radical Prostatectomy – Arthur Burnett, MD

7:20 - 7:40

Role of the Fascial Sling in the Age of Synthetics – Ann Gormley, MD

7:40 - 8:00

Late Onset Hypogonadism: Diagnosis and Treatment - Culley Carson, MD

8:00 - 8:20

Contemporary management of recto urethral fistulas; comparative review of radiated and non radiated etiology – Leonard Zinman, MD

8:20 - 8:40

Break 

8:40 - 9:00

Walking the Tightrope with Ta, T1, and CIS Bladder Cancer – Jim Montie, MD

9:00 - 9:20

Prostate Cancer Biochemical Recurrence - Judd Moul, MD

9:20 - 9:40

Management of Male Incontinence after RRP – Gerald Jordan, MD

9:40 - 10:00

Posterior Urethral Stenosis after Radiation Treatment for Prostate Carcinoma - Jack McAninch, MD

10:00 - 4:00

Break

4:00 - 6:30

Critique Panel

7:15

Awards for Excellence

Friday, February 12, 2010

7:00 - 8:20

What's New In Urology:
What’s New in the Management of Female Incontinence - Victor Nitti, MD
Prostatic Botulinum Type A toxin for LUTS - Kevin McVary, MD
Modern Concepts in the Pathophysiology and Treatment of Priapism-Arthur Burnett, MD
The Potential Role of Nanoparticles in the Formation of Urinary Stone Disease - Marshall Stoller, MD

8:20 - 8:40

Break

8:40 - 9:40

What's New In Urology:
Epidemiology of Fournier’s Gangrene and Strategies for Genital Skin Coverage - Hunter Wessells, MD
Prospective Evaluation of Quality of Life Outcomes for Invasive Treatment of Prostate Cancer – Which Treatment Should I Chose? - Michael Fabrizio, MD

9:40 - 3:30

Break

3:30 - 4:00

Radiographic and Endoscopic Evaluations of the Urethra - Gerald Jordan, MD
Endoscopic Ureteral Stricture Management - Joel Gelman, MD

4:00 - 6:30

Imaging Conference/Case Presentations - (Bring a case/x-rays on a zip drive/CD)